CD200 is induced by ERK and is a potential therapeutic target in melanoma

Immune-mediated antitumor responses occur in patients with metastatic melanoma (MM), and therapies designed to augment such responses are clinically beneficial. Despite the immunogenicity of melanoma, immunomodulatory therapies fail in the majority of patients with MM. An inability of DCs to suffici...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Petermann, Kimberly B., Rozenberg, Gabriela I., Zedek, Daniel, Groben, Pamela, McKinnon, Karen, Buehler, Christin, Kim, William Y., Shields, Janiel M., Penland, Shannon, Bear, James E., Thomas, Nancy E., Serody, Jonathan S., Sharpless, Norman E.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society for Clinical Investigation 2007
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2075477/
https://ncbi.nlm.nih.gov/pubmed/18008004
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI32163
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky